About Us

Prof. Jaya Krishnan has more than 20 years experience in preclinical models and cardiovascular disease research. He completed his PhD at Imperial College London and led research at the ETH-Zurich, Medical Research Council UK and Imperial College London. He currently leads an RNA Therapeutics group in Germany.

​

Dr. Roman Schenk is board member of various health care companies and organizations. Before starting his entrepreneurial career, he held European executive management positions in research, marketing and business development in the pharmaceutical industry.

Jonathan Ward has more than 25 years experience in preclinical research and management. He has held leadership positions in multiple European and Asian biotech companies in the cardiovascular and oncology RNA space, as well as co-founding several successful biotech companies.